Skip to content

Mortality falls in HIV/HCV coinfected Spaniards after the introduction of effective HIV treatment

ICAAC: Switch from AZT or d4T to tenofovir may improve blood fat levels

Non-Hodgkin's lymphoma risk increased with prolonged high HIV viral load

ICAAC: HCV only factor associated with liver problems in patients starting HIV treatment in 2004

ICAAC: Factors unrelated to HIV or side-effects of HIV treatment major cause of illness in French cohort

ICAAC: New treatment for lipid problems shows promise in HIV patients

ICAAC: Moxifloxacin as effective as ethambutol in TB treatment

Limb fat gains lower when switching from AZT to abacavir or tenofovir, compared with d4T

HAART reduces liver damage in HIV / hepatitis C co-infected patients